Literature DB >> 9183006

The in vitro phosphorylation of p53 by calcium-dependent protein kinase C--characterization of a protein-kinase-C-binding site on p53.

C Delphin1, K P Huang, C Scotto, A Chapel, M Vincon, E Chambaz, J Garin, J Baudier.   

Abstract

We show that, in vitro, Ca2+-dependent protein kinase C (PKC) phosphorylates recombinant murine p53 protein on several residues contained within a conserved basic region of 25 amino acids, located in the C-terminal part of the protein. Accordingly, synthetic p53-(357-381)-peptide is phosphorylated by PKC at multiple Ser and Thr residues, including Ser360, Thr365, Ser370 and Thr377. We also establish that p53-(357-381)-peptide at micromolar concentrations has the ability to stimulate sequence-specific DNA binding by p53. That stimulation is lost upon phosphorylation by PKC. To further characterise the mechanisms that regulate PKC-dependent phosphorylation of p53-(357-381)-peptide, the phosphorylation of recombinant p53 and p53-(357-381)-peptide by PKC were compared. The results suggest that phosphorylation of full-length p53 on the C-terminal PKC sites is highly dependent on the accessibility of the phosphorylation sites and that a domain on p53 distinct from p53-(357-381)-peptide is involved in binding PKC. Accordingly, we have identified a conserved 27-amino-acid peptide, p53-(320-346)-peptide, within the C-terminal region of p53 and adjacent to residues 357-381 that interacts with PKC in vitro. The interaction between p53-(320-346)-peptide and PKC inhibits PKC autophosphorylation and the phosphorylation of substrates, including p53-(357-381)-peptide, neurogranin and histone H1. Conventional Ca2+-dependent PKC alpha, beta and gamma and the catalytic fragment of PKC (PKM) were nearly equally susceptible to inhibition by p53-(320-346)-peptide. The Ca2+-independent PKC delta was much less sensitive to inhibition. The significance of these findings for understanding the in vivo phosphorylation of p53 by PKC are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9183006     DOI: 10.1111/j.1432-1033.1997.t01-1-00684.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Protein kinase CK2 interacts with a multi-protein binding domain of p53.

Authors:  C Götz; P Scholtes; A Prowald; N Schuster; W Nastainczyk; M Montenarh
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo.

Authors:  Stephen D Smith; Martin Enge; Wenjie Bao; Minna Thullberg; Tânia D F Costa; Helene Olofsson; Behxhet Gashi; Galina Selivanova; Staffan Strömblad
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

3.  Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.

Authors:  C A Pise-Masison; R Mahieux; H Jiang; M Ashcroft; M Radonovich; J Duvall; C Guillerm; J N Brady
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

4.  Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C.

Authors:  C Scotto; C Delphin; J C Deloulme; J Baudier
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

5.  Copper uptake is required for pyrrolidine dithiocarbamate-mediated oxidation and protein level increase of p53 in cells.

Authors:  Saori Furuta; Fausto Ortiz; Xiu Zhu Sun; Hsiao-Huei Wu; Andrew Mason; Jamil Momand
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

6.  p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation.

Authors:  J Xu; G F Morris
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  A fluid salt-bridging cluster and the stabilization of p53.

Authors:  Thu Zar Lwin; Jason J Durant; Donald Bashford
Journal:  J Mol Biol       Date:  2007-08-24       Impact factor: 5.469

8.  Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.

Authors:  Sárka Pospísilová; Václav Brázda; Katerina Kucharíková; M Gloria Luciani; Ted R Hupp; Petr Skládal; Emil Palecek; Borivoj Vojtesek
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

Review 9.  p53: the attractive tumor suppressor in the cancer research field.

Authors:  Toshinori Ozaki; Akira Nakagawara
Journal:  J Biomed Biotechnol       Date:  2010-12-06

10.  Specific recognition of p53 tetramers by peptides derived from p53 interacting proteins.

Authors:  Ronen Gabizon; Tobias Brandt; Shahar Sukenik; Noa Lahav; Mario Lebendiker; Deborah E Shalev; Dmitry Veprintsev; Assaf Friedler
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.